Alzheimer's risk may be 35% lower with common menopause treatment, study finds

Women who used estrogen-only menopausal hormone therapy (MHT) were less likely to develop Alzheimer’s-related brain changes or dementia, according to a large Stanford study published Aug. 12 in Neurology. The researchers analyzed post-mortem data from 21,462 participants, comparing 258 women who reported estrogen-only MHT use with approximately 2,701 women who reported no MHT use. The researchers examined the brains for signs of Alzheimer’s disease , including amyloid plaques, neurofibrillary ta